132 related articles for article (PubMed ID: 34532292)
1. Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.
Frontiers Editorial Office
Front Oncol; 2021; 11():738970. PubMed ID: 34532292
[TBL] [Abstract][Full Text] [Related]
2. RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.
Luo C; Zhu X; Luo Q; Bu F; Huang C; Zhu J; Zhao J; Zhang W; Lin K; Hu C; Zong Z; Luo H; Huang J; Zhu Z
Front Oncol; 2020; 10():1044. PubMed ID: 32903312
[TBL] [Abstract][Full Text] [Related]
3. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
[TBL] [Abstract][Full Text] [Related]
4. Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1298859. PubMed ID: 38115901
[TBL] [Abstract][Full Text] [Related]
5. Retraction: RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway.
Frontiers Editorial Office
Front Oncol; 2020; 10():607586. PubMed ID: 33194774
[TBL] [Abstract][Full Text] [Related]
6. Retraction: The Collective Effect of MIP-3α and FL Promotes Dendritic Cell Function Within the Immune Microenvironment of Murine Liver Cancer.
Frontiers Editorial Office
Front Oncol; 2021; 11():744389. PubMed ID: 34497774
[TBL] [Abstract][Full Text] [Related]
7. Retraction: lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p.
Frontiers Editorial Office
Front Oncol; 2021; 11():841478. PubMed ID: 35036363
[TBL] [Abstract][Full Text] [Related]
8. Retraction: ZNF655 promotes the progression of glioma through transcriptional regulation of AURKA.
Frontiers Editorial Office
Front Oncol; 2023; 13():1294900. PubMed ID: 38023237
[TBL] [Abstract][Full Text] [Related]
9. Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Frontiers Editorial Office
Front Oncol; 2021; 11():840152. PubMed ID: 35036360
[TBL] [Abstract][Full Text] [Related]
10. Retraction: LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer
Frontiers Editorial Office
Front Oncol; 2021; 11():840907. PubMed ID: 35087764
[TBL] [Abstract][Full Text] [Related]
11. Retraction: OTUB2 facilitates tumorigenesis of gastric cancer through promoting KDM1A-mediated stem cell-like properties.
Frontiers Editorial Office
Front Oncol; 2023; 13():1209867. PubMed ID: 37287909
[TBL] [Abstract][Full Text] [Related]
12. Retraction: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma
Frontiers Editorial Office
Front Oncol; 2021; 11():761874. PubMed ID: 34557422
[TBL] [Abstract][Full Text] [Related]
13. Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer.
Office FE
Front Oncol; 2023; 13():1228367. PubMed ID: 37377910
[TBL] [Abstract][Full Text] [Related]
14. Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis.
Frontiers Editorial Office
Front Oncol; 2021; 11():840086. PubMed ID: 35036359
[TBL] [Abstract][Full Text] [Related]
15. Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1294881. PubMed ID: 37841426
[TBL] [Abstract][Full Text] [Related]
16. Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.
Frontiers Editorial Office
Front Oncol; 2021; 11():694036. PubMed ID: 34041039
[TBL] [Abstract][Full Text] [Related]
17. Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8.
Frontiers Editorial Office
Front Oncol; 2023; 13():1307324. PubMed ID: 37927471
[TBL] [Abstract][Full Text] [Related]
18. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction.
Wang L; Sun L; Wang Y; Yao B; Liu R; Chen T; Tu K; Liu Q; Liu Z
Int J Biol Sci; 2022; 18(10):3942. PubMed ID: 35844782
[TBL] [Abstract][Full Text] [Related]
19. Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells
Frontiers Editorial Office
Front Oncol; 2021; 11():759578. PubMed ID: 34557421
[TBL] [Abstract][Full Text] [Related]
20. Retraction: Exosomes from cancer-associated mesenchymal stem cells transmit TMBIM6 to promote the malignant behavior of hepatocellular carcinoma via activating PI3K/AKT pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1307333. PubMed ID: 37927479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
